CN Patent

CN114557977A — 一种治疗肠癌的药物的制备方法、制剂及纯度分析方法

Assigned to Beijing Kang Lisheng Pharmaceutical Technology Development Co ltd · Expires 2022-05-31 · 4y expired

What this patent protects

本发明属于化学药物领域，具体涉及一种治疗肠癌的药物、制备方法、制剂、分析方法。该合成路线具有路线短、收率高、易产业化、成本低的优点，本发明制剂是一种康奈非尼合适的盐的固体分散体技术，可加快康奈非尼在肠胃的吸收，上述康奈非尼合适的盐是指康奈非尼双盐酸盐、康奈非尼双甲磺酸盐。本发明有助于缓解中国的抗肠癌药物的可及性问题。

USPTO Abstract

本发明属于化学药物领域，具体涉及一种治疗肠癌的药物、制备方法、制剂、分析方法。该合成路线具有路线短、收率高、易产业化、成本低的优点，本发明制剂是一种康奈非尼合适的盐的固体分散体技术，可加快康奈非尼在肠胃的吸收，上述康奈非尼合适的盐是指康奈非尼双盐酸盐、康奈非尼双甲磺酸盐。本发明有助于缓解中国的抗肠癌药物的可及性问题。

Drugs covered by this patent

Patent Metadata

Patent number
CN114557977A
Jurisdiction
CN
Classification
—
Expires
2022-05-31
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Kang Lisheng Pharmaceutical Technology Development Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.